Publication Date:
2016-09-08
Description:
Safety and efficacy of the combination of pegylated interferon-α2b and dasatinib in newly diagnosed chronic-phase chronic myeloid leukemia patients Leukemia 30, 1853 (September 2016). doi:10.1038/leu.2016.121 Authors: H Hjorth-Hansen, J Stentoft, J Richter, P Koskenvesa, M Höglund, A Dreimane, K Porkka, T Gedde-Dahl, B T Gjertsen, F X Gruber, L Stenke, K M Eriksson, B Markevärn, A Lübking, H Vestergaard, L Udby, O W Bjerrum, I Persson, S Mustjoki & U Olsson-Strömberg
Print ISSN:
0887-6924
Electronic ISSN:
1476-5551
Topics:
Medicine
Permalink